Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vericel Corp Director's Dealing 2011

Oct 24, 2011

31799_dirs_2011-10-24_97fcd9df-5061-4087-8ece-e76675da5cdf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AASTROM BIOSCIENCES INC (ASTM)
CIK: 0000887359
Period of Report: 2011-10-13

Reporting Person: Gibson Brian (Vice President)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $1.48 2020-07-14 Common Stock (70000) Direct
Stock Option (right to buy) $1.49 2020-09-22 Common Stock (5000) Direct
Stock Option (right to buy) $2.26 2021-03-11 Common Stock (70000) Direct

Footnotes

F1: These options were granted on July 14, 2010 with 25% vesting on the first anniversary of the date of grant and 6.25% vesting each quarter thereafter.

F2: These options were granted on September 22, 2010 and vest quarterly over four years commencing on the date of grant.

F3: These options were granted on March 11, 2011 and vest quarterly over four years commencing on the date of grant.